Health Policy

A new study from Associate Dean of Research Alison Cuellar found that independent practices experienced a smaller drop in patient volume than consolidated practices during the height of the Covid-19 pandemic. 

Braun is a leading expert on private equity investments in health care and studies how private equity ownership impacts the quality of patient care in facilities like nursing homes or rehabilitation centers. Braun credits his experience at Mason for giving him a platform to grow into a national researcher and health policy leader.

George Mason Associate Professor of Health Administration and Policy discusses the importance of job-protected paid leave.

Anand Discusses Research on Paid Family Leave with U.S. Policymakers 

COVID vaccine coverage questions abound for health insurers

Paid leave mandates reduce likelihood of decreasing paid work hours after a spouse’s health shock, study shows.

Paid leave policies do not always include job protection: US President's 2022 Economic Report

CHHS welcomes Dr. Jeah Jung to the Health Administration and Policy faculty. Jung brings research expertise in health economics, health policy, and health disparities.

In a recent study, George Mason University Associate Professor Hong Xue, PhD and colleagues evaluated the impact of ending market exclusivity for brand-name statin drugs. The first study to comprehensively assess the economic impact of generic competition for statins found that ending market exclusivity for statins saves U.S. $12 billion and individuals nearly $1,000 annually.